Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Relative Value
The Relative Value of one
HAPV3
stock under the Base Case scenario is
hidden
BRL.
Compared to the current market price of 9.56 BRL,
Hapvida Participacoes e Investimentos SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HAPV3 Competitors Multiples
Hapvida Participacoes e Investimentos SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
4.7B BRL | 0.3 | -9.9 | 2.6 | 4.6 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
260.2B USD | 0.6 | 21.6 | 0 | 0 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
73.3B USD | 0.4 | 13 | 0 | 0 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
63.8B USD | 0.3 | 11.3 | 0 | 0 | |
| US |
|
Humana Inc
NYSE:HUM
|
21.6B USD | 0.2 | 18.2 | 0 | 0 | |
| US |
|
Centene Corp
NYSE:CNC
|
21.5B USD | 0.1 | -3.2 | 0 | 0 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
7.5B USD | 0.2 | 15.8 | 3.2 | 4 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 5.1 | 34.5 | 16 | 24.4 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 0.5 | 8.5 | 12.9 | 38.5 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 1.2 | 25.5 | 12.4 | 13 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
7.4B BRL | 3.1 | 12.8 | 8.6 | 9.3 |